Cancer-related fatigue: the scale of the problem

Clicks: 273
ID: 273953
2007
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #12 of 15 articles by views in the oncologist

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Fatigue is one of the most common and debilitating symptoms experienced by patients with cancer. Cancer-related fatigue (CRF) is characterized by feelings of tiredness, weakness, and lack of energy, and is distinct from the "normal" drowsiness experienced by healthy individuals in that it is not rel …
Reference Key
m2007thecancer-related Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hofman M;Ryan JL;Figueroa-Moseley CD;Jean-Pierre P;Morrow GR;;
Journal the oncologist
Year 2007
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17573451&dopt=Abstract
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't N.I.H. Extramural neoplasms / complications* quality of life neoplasms / epidemiology pmid:17573451 doi:10.1634/theoncologist.12-s1-4 maarten hofman julie l ryan gary r morrow fatigue / epidemiology fatigue / etiology* fatigue / psychology neoplasms / psychology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.